Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Chloroquine Phosphate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 30Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Suven Pharms's Generic Chloroquine Phosphate Receives Approval in the US
    Suven Pharms's Generic Chloroquine Phosphate Receives Approval in the US

    03 Sep 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214756

    FDA
    03 Sep 2021
    Share Share
    EMA/PRAC reiterates psychiatric disorder risk for chloroquine and HCQ
    EMA/PRAC reiterates psychiatric disorder risk for chloroquine and HCQ

    30 Nov 2020

    // THEPHARMALETTER

    https://www.thepharmaletter.com/article/ema-prac-reiterates-psychiatric-disorder-risk-for-chloroquine-and-hydroxychloroquine

    THEPHARMALETTER
    30 Nov 2020
    Share Share
    FDA Alarmed Over Bayer's Chloroquine Donation to the U.S. Amid COVID-19 Pandemic
    FDA Alarmed Over Bayer's Chloroquine Donation to the U.S. Amid COVID-19 Pandemic

    06 Aug 2020

    // Tiziana Celine TECHTIMES

    https://www.techtimes.com/articles/248904/20200416/breaking-coronavirus-fda-alarmed-over-bayers-chloroquine-donation-to-the-u-s-amid-covid-19-pandemic.htm

    Tiziana Celine TECHTIMES
    06 Aug 2020
    Share Share
    FDA Revokes Emergency Use Authorization For Highly Watched Chloroquine & HCQ
    FDA Revokes Emergency Use Authorization For Highly Watched Chloroquine & HCQ

    23 Jun 2020

    // JDSUPRA

    https://www.jdsupra.com/legalnews/fda-revokes-emergency-use-authorization-13997/

    JDSUPRA
    23 Jun 2020
    Share Share
    Import alert for APls Chloroquine Phosphate-IPCA
    Import alert for APls Chloroquine Phosphate-IPCA

    23 Jun 2020

    // BSEINDIA

    https://www.bseindia.com/xml-data/corpfiling/AttachLive/fbb2b614-56f1-4f51-b5ad-be12ed2fa3a3.pdf

    BSEINDIA
    23 Jun 2020
    Share Share
    The US now has 66 million surplus anti-malaria pills after the FDA revoked an emergency waiver allowing chloroquine and HCQ
    The US now has 66 million surplus anti-malaria pills after the FDA revoked an emergency waiver allowing chloroquine and HCQ

    18 Jun 2020

    // BILL BOSTOCK BUSINESSINSIDER

    https://www.businessinsider.in/international/news/the-us-now-has-66-million-surplus-anti-malaria-pills-after-the-fda-revoked-an-emergency-waiver-allowing-chloroquine-and-hydroxychloroquine/articleshow/76422888.cms

    BILL BOSTOCK BUSINESSINSIDER
    18 Jun 2020
    Share Share